- Lung cancer screening software, designed to facilitate early detection and streamline diagnostic workflows, is becoming a critical tool in radiology departments and cancer care centers across North America due to its ability to enhance screening accuracy, patient tracking, and data integration within healthcare systems
- The rising demand for lung cancer screening software is primarily fueled by the growing prevalence of lung cancer, increasing emphasis on early detection programs, and government-backed screening guidelines such as those from the U.S. Preventive Services Task Force (USPSTF).
- U.S. dominated the North America lung cancer screening software market with the largest revenue share of 58.5% in 2024, supported by a mature healthcare IT infrastructure, favorable reimbursement policies, and proactive implementation of AI-driven solutions in radiology
- Canada is expected to be the fastest growing region in the North America lung cancer screening software market, due to rising awareness, improved screening access, and national lung screening initiatives
- The standalone segment dominated the North America lung cancer screening software market with a share of 62% in 2024, owing to its compatibility with existing hospital information systems (HIS) and its ability to provide scalable, vendor-neutral integration across various imaging platforms.
